Holen Sie sich die Stockscreener-App
7.63
6.72%
-0.55
Handel nachbörslich:
7.70
0.07
+0.92%
Schlusskurs vom Vortag:
$8.18
Offen:
$8.37
24-Stunden-Volumen:
2.21M
Relative Volume:
1.16
Marktkapitalisierung:
$559.52M
Einnahmen:
$11.40B
Nettoeinkommen (Verlust:
$-95.73M
KGV:
-3.1143
EPS:
-2.45
Netto-Cashflow:
$-64.37M
1W Leistung:
-22.85%
1M Leistung:
+6.27%
6M Leistung:
+19.03%
1J Leistung:
+65.15%
1-Tages-Spanne:
$7.625
$8.50
1-Wochen-Bereich:
$7.625
$10.35
52-Wochen-Spanne:
$4.54
$12.22
Mind Medicine Inc Stock (MNMD) Company Profile
Firmenname
Mind Medicine Inc
Sektor
Branche
Telefon
212-220-6633
Adresse
ONE WORLD TRADE CENTER, NEW YORK
Vergleichen Sie MNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
7.63 | 559.52M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-28 | Eingeleitet | Evercore ISI | Outperform |
| 2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-10-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-07-24 | Eingeleitet | ROTH MKM | Buy |
| 2024-05-29 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-15 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-12-09 | Fortgesetzt | ROTH Capital | Buy |
| 2022-11-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-26 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Eingeleitet | ROTH Capital | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Mind Medicine Inc Aktie (MNMD) Neueste Nachrichten
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months - MSN
When the Price of (MNMD) Talks, People Listen - Stock Traders Daily
Can MindMed's 2024 Financial Results Reveal Its Brain Health Pipeline Progress? - StockTitan
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3%Time to Sell? - MarketBeat
Mind Medicine (MindMed) (MNMD) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's What Happened - MarketBeat
Why Mind Medicine Stock Is Skyrocketing Today - MSN
OPNTMindMed Strengthens Board with Appointment of Two New Independent Directors - br.ADVFN.com
Mind Medicine (MNMD) Stock Surges on RFK Jr.'s HHS Confirmation - GuruFocus.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 9%Time to Sell? - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 5.5%Still a Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
What is HC Wainwright's Forecast for MNMD FY2029 Earnings? - MarketBeat
Mind Medicine’s LSD Therapy Could Revolutionize Anxiety Treatment – Is It a Buy? - PUNE.NEWS
Mind Medicine (MNMD) Advances Groundbreaking LSD Treatment - Markets Insider
Mind Medicine (MindMed) (OTCMKTS:MMEDF) Stock Price Up 10.9% – Still a Buy? - Defense World
BlackRock, Inc.'s Strategic Acquisition of Mind Medicine Inc Sha - GuruFocus.com
Leerink Partnrs Issues Negative Forecast for MNMD Earnings - MarketBeat
MindMed to Present at Oppenheimer Healthcare Conference - TipRanks
MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of “Buy” by Brokerages - Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5%Time to Buy? - MarketBeat
Analysts Issue Forecasts for MNMD FY2029 Earnings - Defense World
Mind Medicine (MindMed)’s (MNMD) Buy Rating Reiterated at HC Wainwright - Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Evercore ISI - MarketBeat
Q1 Earnings Estimate for MNMD Issued By Leerink Partnrs - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
JPMorgan Chase & Co. Buys 2,797 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Analysts at Evercore ISI - MarketBeat
MNMDMind Medicine (MindMed) Inc. Common Shares Latest Stock News & Market Updates - StockTitan
Finanzdaten der Mind Medicine Inc-Aktie (MNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):